Literature DB >> 7504370

In vivo priming and activation of memory cytotoxic T-lymphocytes (CTL) by a chimeric simian virus 40 T antigen expressing an eight amino acid residue herpes simplex virus gB CTL epitope.

R H Bonneau1, T M Fu, S S Tevethia.   

Abstract

The simian virus 40 (SV40) large T antigen was used as an immunogenic vector to express a herpes simplex virus type 1 (HSV-1) glycoprotein B (gB), H-2Kb-restricted cytotoxic T lymphocyte (CTL) recognition epitope corresponding to amino acid residues 498-505. Immunization of naive, C57BL/6 mice with a cell line, B6/350gB, expressing the chimeric T antigen was able to induce the generation of gB498-505-specific CTL in both the lymph nodes and the spleen. Splenic-derived, gB498-505-specific memory CTL (CTLm) were detected in these mice for at least 6 months following immunization at a slightly lower frequency than in those mice immunized with infectious HSV-1. B6/350gB was also able to activate in vitro gB498-505-specific memory CTL obtained from mice previously challenged with HSV. Overall, these findings support the use of a chimeric T antigen as a vector in determining the immunogenic potential of individual CTL epitopes and to assess their potential contribution in inducing a protective immune response in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504370     DOI: 10.1006/viro.1993.1657

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  The early expression of glycoprotein B from herpes simplex virus can be detected by antigen-specific CD8+ T cells.

Authors:  Scott N Mueller; Claerwen M Jones; Weisan Chen; Yoshihiro Kawaoka; Maria R Castrucci; William R Heath; Francis R Carbone
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

2.  Analysis of the cytolytic T-lymphocyte response to herpes simplex virus type 1 glycoprotein B during primary and secondary infection.

Authors:  C T Nugent; R M Wolcott; R Chervenak; S R Jennings
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

3.  Immunization with a replication-deficient mutant of herpes simplex virus type 1 (HSV-1) induces a CD8+ cytotoxic T-lymphocyte response and confers a level of protection comparable to that of wild-type HSV-1.

Authors:  M A Brehm; R H Bonneau; D M Knipe; S S Tevethia
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

4.  Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.

Authors:  J E Blaney; E Nobusawa; M A Brehm; R H Bonneau; L M Mylin; T M Fu; Y Kawaoka; S S Tevethia
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

5.  Antiviral protective immunity induced by major histocompatibility complex class I molecule-restricted viral T-lymphocyte epitopes inserted in various positions in immunologically self and nonself proteins.

Authors:  G Weidt; W Deppert; S Buchhop; H Dralle; F Lehmann-Grube
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

6.  Polymorphism within the herpes simplex virus (HSV) ribonucleotide reductase large subunit (ICP6) confers type specificity for recognition by HSV type 1-specific cytotoxic T lymphocytes.

Authors:  L A Salvucci; R H Bonneau; S S Tevethia
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.